Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling.
about
Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significance.ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression.
P2860
Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of therapeutic ...... ive tyrosine kinase profiling.
@ast
Identification of therapeutic ...... ive tyrosine kinase profiling.
@en
type
label
Identification of therapeutic ...... ive tyrosine kinase profiling.
@ast
Identification of therapeutic ...... ive tyrosine kinase profiling.
@en
prefLabel
Identification of therapeutic ...... ive tyrosine kinase profiling.
@ast
Identification of therapeutic ...... ive tyrosine kinase profiling.
@en
P2860
P50
P356
P1433
P1476
Identification of therapeutic ...... ive tyrosine kinase profiling.
@en
P2093
Atanasio Pandiella
P2860
P304
30057-30071
P356
10.18632/ONCOTARGET.4996
P407
P577
2015-08-13T00:00:00Z